Theodore Amgott
Pulmonary Disease · Melbourne, FLNPI 1861485518
Payments from drug & device makers
Across 180 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$747
- Boehringer Ingelheim$597
- GSK$539
- Grifols USA, LLC$253
- Genentech USA, Inc.$121
- Merck$79
- plus $464 from 16 others
What the payments were for
- Food & beverage$2,64394%
- Education$1576%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 48 | $747 |
| Boehringer Ingelheim | 38 | $597 |
| GSK | 43 | $539 |
| Grifols USA, LLC | 13 | $253 |
| Genentech USA, Inc. | 4 | $121 |
| Merck | 5 | $79 |
| Electromed, Inc. | 5 | $55 |
| Advanced Respiratory, Inc | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Philips North America LLC | 2 | $33 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| Sanofi | 2 | $31 |
| Novartis | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| United Therapeutics Corporation | 1 | $21 |
| Shire North American Group Inc | 1 | $19 |
| Amgen | 1 | $17 |
| CSL Behring | 1 | $17 |
| Circassia Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolastin-C$125
How this compares
$2,800 in reported general payments places this provider in the 40th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Melbourne
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
- Carlos MartinezHomestead$9.2M
- Leonard DunnDunedin$7.6M
- Francis AverillClearwater$6.3M
- Charles BurgerJacksonville$5.6M
- Daniel LorchBrandon$5.5M
- Lourdes BoschMiami$4.2M
- Raj KarunakaraOcala$4M
- Neal WarshoffLoxahatchee$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.